Your session is about to expire
← Back to Search
Other
Rapid Rollover for Collapsed Lung
N/A
Recruiting
Led By Jae Ho Sohn, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours for overnight observation
Awards & highlights
Study Summary
This trial is testing whether a maneuver called "rapid rollover" can help reduce the risk of pneumothorax (collapsed lung) after a CT-guided lung biopsy.
Who is the study for?
This trial is for patients needing a CT-guided lung biopsy at the Department of Radiology and Biomedical Imaging. It's not suitable for those who can't be repositioned due to spine issues, have certain lesion locations, or develop specific complications during the procedure.Check my eligibility
What is being tested?
The study tests if 'rapid rollover'—turning patients so the biopsy side is down right after needle removal—can reduce collapsed lung risk post-biopsy. Participants are randomly assigned to either try this technique or follow standard care.See study design
What are the potential side effects?
Potential side effects include risks associated with CT-guided lung biopsies such as pain at the biopsy site, bleeding, and rarely more serious complications like air trapped in the chest cavity requiring medical intervention.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 hours for overnight observation
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours for overnight observation
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Radiographically detectable pneumothorax
Secondary outcome measures
Chest tube insertion
Enlarging pneumothorax
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Rapid RolloverExperimental Treatment1 Intervention
Participants will have their body re-positioned upon being transferred to the stretcher from the CT scanner table such that the biopsy site is down. Participants will be maintained in the same position for the post-biopsy CT scanner as well as in the post-procedure recovery area for a minimum of 2 hours.
Group II: ControlActive Control1 Intervention
CT-guided lung biopsy will be performed per standard protocols
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,505 Previous Clinical Trials
15,237,429 Total Patients Enrolled
Jae Ho Sohn, MDPrincipal InvestigatorUniversity of California, San Francisco
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I cannot be moved or repositioned easily due to my condition.My cancer is located in the chest wall, near the lung surface, or in the central chest area.I had a chest tube inserted due to bleeding in the chest.I am referred for a CT-guided lung biopsy by the Cardiac and Pulmonary Imaging section.I developed a collapsed lung during a medical procedure.My biopsy was done with me lying on my stomach.Patients who are moved during a procedure.
Research Study Groups:
This trial has the following groups:- Group 1: Rapid Rollover
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this trial currently accepting new participants?
"Affirmative. Clinicaltrials.gov reveals that this clinical trial is seeking participants and has been since September 15th, 2022 - the same date it was last updated. 126 patients must be recruited from 2 sites to complete the study."
Answered by AI
Approximately how many people have volunteered for this research program?
"Affirmative, clinicaltrials.gov hosts data that indicates this trial is currently conscripting participants; the inaugural posting was on September 15th 2022 and has since been refreshed as of the same date. This study seeks to recruit 126 patients from two different sites."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger